Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
HLN · against 70 other Healthcare companies of similar size
Ranked #30 of 71 · scores higher than 59% of peers · safety percentile 39
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)13 peers with a safety percentile of 30–39, including HLN · Click a bar to see the companies
A mix: stronger beta, but weaker current ratio and debt / equity than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | HLN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 67 reported | 0.50× | 0.50× | 50% | 33% | |
| BetaLower is better · 68 reported | 0.24 | 0.74 | 79% | 33% | |
| Current ratioHigher is better · 67 reported | 0.69× | 1.86× | 0% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 26.0B USD | 93 | 28 | |
| 2 | 327.3B CNY (≈$45.8B) | 92 | 75 | |
| 3 | 56.7B USD | 85 | 79 | |
| 4 | 8.24T JPY (≈$56.0B) | 83 | 75 | |
| 5 | 25.8B USD | 83 | 75 | |
| 26 | 28.6B USD | 48 | 60 | |
| 27 | 35.0B USD | 48 | 52 | |
| 28 | 32.3B AUD (≈$21.3B) | 47 | 55 | |
| 29 | 22.6B USD | 39 | 59 | |
| 30 | 38.9B USD | 39 | 56 | |
| 31 | 56.0B USD | 37 | 39 | |
| 32 | 64.8B EUR (≈$71.3B) | 35 | 51 | |
| 33 | 4.61T JPY (≈$31.3B) | 35 | 76 | |
| 34 | 22.8B USD | 34 | 38 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score